WC
VBIV

Weil Company’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Weil Company’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-987
Closed -$99K – 152
2021
Q2 		$99K Sell
987
-903
-48% -$88K 0.05% 145
2021
Q1 		$176K Sell
1,890
-1,090
-37% -$111K 0.1% 140
2020
Q4 		$246K Buy
2,980
+500
+20% +$42.6K 0.15% 118
2020
Q3 		$213K Sell
2,480
-51
-2% -$5.94K 0.16% 100
2020
Q2 		$235K Buy
2,531
+500
+25% +$27.5K 0.2% 84
2020
Q1 		$58K Sell
2,031
-1,000
-33% -$38.9K 0.05% 94
2019
Q4 		$125K Sell
3,031
-532
-15% -$11.6K 0.1% 106
2019
Q3 		$50K Buy
3,563
+1,167
+49% +$24.4K 0.04% 194
2019
Q2 		$84K Buy
2,396
+1,667
+229% +$90.4K 0.07% 98
2019
Q1 		$41K Buy
+729
New +$39.4K 0.03% 101

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return